524
Participants
Start Date
October 2, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
April 30, 2026
Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody
ACIP Recommended Preventive Monoclonal Antibody
NOT_YET_RECRUITING
Columbia University, New York
RECRUITING
Duke University, Durham
RECRUITING
Emory University, Atlanta
ACTIVE_NOT_RECRUITING
Centers for Disease Control and Prevention, Atlanta
NOT_YET_RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
NOT_YET_RECRUITING
Kaiser Permanente Northern California, Oakland
Lead Sponsor
Centers for Disease Control and Prevention
FED
Children's Hospital Medical Center, Cincinnati
OTHER
Columbia University
OTHER
Emory University
OTHER
Kaiser Permanente
OTHER
Duke University
OTHER